COVID-19: Caring for Patients and Communities
An immunologist at Johns Hopkins University (JHU) in Baltimore, Md., is working to develop a blood-derived treatment for use against COVID-19. The technique uses antibodies from the blood plasma or serum of people who have recovered from the infection. If all goes well, the team says, it may be…